As the Lenalidomide Drug Market continues to evolve, several market drivers are shaping its trajectory. The increasing prevalence of blood cancers, including multiple myeloma and mantle cell lymphoma, serves as a significant driver propelling market growth. Moreover, the rising geriatric population, particularly in developed regions, contributes to the growing demand for lenalidomide-based treatments. Additionally, advancements in medical research and technology are expanding the ... Read more
